Impact of adjuvant hormonotherapy on radiation-induced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trial.
Fiche publication
Date publication
mars 2018
Journal
Oncotarget
Auteurs
Membres identifiés du Cancéropôle Est :
Pr NOEL Georges, Dr PEIGNAUX Karine
Tous les auteurs :
Bourgier C, Castan F, Riou O, Nguyen TD, Peignaux K, Lemanski C, Lagrange JL, Kirova Y, Lartigau E, Belkacemi Y, Rivera S, Noël G, Clippe S, Mornex F, Hennequin C, Gourgou S, Brengues M, Fenoglietto P, Ozsahin EM, Azria D
Lien Pubmed
Résumé
To evaluate risk of severe breast fibrosis occurrence in patients treated by breast-conserving surgery, adjuvant radiotherapy and hormonotherapy (HT) according to individual radiosensitivity (RILA assay).
Mots clés
breast cancer, hormonotherapy, individual radiosensitivity, late effects, radiotherapy
Référence
Oncotarget. 2018 Mar 20;9(21):15757-15765